Imaging structure and function in refractory focal epilepsy

Lancet Neurology

Volumn 4, Issue 1, 2005, Pages 42-53

  Koepp, Matthias J ^a,c   Woermann, Friedrich G ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b EPILEPSY CENTER BETHEL   (Germany)

^c EPILEPSY SOCIETY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN FUNCTION; BRAIN MALFORMATION; BRAIN NERVE CELL; BRAIN SURGERY; BRAIN TUMOR; CELL FUNCTION; COGNITION; ELECTROENCEPHALOGRAM; FOCAL EPILEPSY; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; LANGUAGE; MEMORY; NEUROANATOMY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PELIZAEUS MERZBACHER DISEASE; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE EPILEPSY; TREATMENT OUTCOME; VERBAL MEMORY;

BRAIN NEOPLASMS; COGNITION; ELECTROENCEPHALOGRAPHY; EPILEPSIES, PARTIAL; HUMANS; MAGNETIC RESONANCE IMAGING; MEMORY; POSITRON-EMISSION TOMOGRAPHY;

EID: 11144299553     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(04)00965-2     Document Type: Review

References (151)

1. Semah F, Picot MC, Adam C, et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology. 51:1998;1256-1262
2. Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 345:2001;311-318
3. Wyllie E, Comair YG, Kotagal P, Bulacio J, Bingaman W, Ruggieri P. Seizure outcome after epilepsy surgery in children and adolescents. Ann Neurol. 44:1998;740-748
4. Cohen-Gadol AA, Ozduman K, Bronen RA, Kim JH, Spencer DD. Long-term outcome after epilepsy surgery for focal cortical dysplasia. J Neurosurg. 101:2004;55-65
5. Salanova V, Markand O, Worth R. Temporal lobe epilepsy: analysis of patients with dual pathology. Acta Neurol Scand. 109:2004;126-131
6. Rosenow F, Luders H. Presurgical evaluation of epilepsy. Brain. 124:2001;1683-1700
7. Li LM, Fish DR, Sisodiya SM, Shorvon SD, Alsanjari N, Stevens JM. High resolution magnetic resonance imaging in adults with partial or secondary generalised epilepsy attending a tertiary referral unit. J Neurol Neurosurg Psychiatry. 59:1995;384-387
8. Liu RS, Lemieux L, Bell GS, et al. Progressive neocortical damage in epilepsy. Ann Neurol. 53:2003;312-324
9. Liu RS, Lemieux L, Bell GS, et al. The structural consequences of newly diagnosed seizures. Ann Neurol. 52:2002;573-580
10. King MA, Newton MR, Jackson GD, et al. Epileptology of the first-seizure presentation: a clinical, electroencephalographic, and magnetic resonance imaging study of 300 consecutive patients. Lancet. 352:1998;1007-1111
11. Engel J. Jr. Introduction to temporal lobe epilepsy. Epilepsy Res. 26:1996;141-150
12. Jack CR Jr, Sharbrough FW, Twomey CK, et al. Temporal lobe seizures: lateralization with MR volume measurements of the hippocampal formation. Radiology. 175:1990;423-429
13. Jackson GD, Connelly A, Duncan JS, Grunewald RA, Gadian DG. Detection of hippocampal pathology in intractable partial epilepsy: increased sensitivity with quantitative magnetic resonance T2 relaxometry. Neurology. 43:1993;1793-1799
14. Woermann FG, Barker GJ, Birnie KD, Meencke HJ, Duncan JS. Regional changes in hippocampal T2 relaxation and volume: a quantitative magnetic resonance imaging study of hippocampal sclerosis. J Neurol Neurosurg Psychiatry. 65:1998;656-664
15. Bronen RA, Fulbright RK, Kim JH, Spencer SS, Spencer DD. A systematic approach for interpreting MR images of the seizure patient. Am J Roentgenol. 169:1997;241-247
16. Cendes F, Cook MJ, Watson C, et al. Frequency and characteristics of dual pathology in patients with lesional epilepsy. Neurology. 45:1995;2058-2064
17. Keller SS, Mackay CE, Barrick TR, Wieshmann UC, Howard MA, Roberts N. Voxel-based morphometric comparison of hippocampal and extrahippocampal abnormalities in patients with left and right hippocampal atrophy. Neuroimage. 16:2002;23-31
18. Pell GS, Briellmann RS, Waites AB, Abbott DF, Jackson GD. Voxel-based relaxometry: a new approach for analysis of T2 relaxometry changes in epilepsy. Neuroimage. 21:2004;707-713
19. Bernasconi N, Bernasconi A, Caramanos Z, Antel SB, Andermann F, Arnold DL. Mesial temporal damage in temporal lobe epilepsy: a volumetric MRI study of the hippocampus, amygdala and parahippocampal region. Brain. 126:2003;462-469
20. Bonilha L, Kobayashi E, Rorden C, Cendes F, Li LM. Medial temporal lobe atrophy in patients with refractory temporal lobe epilepsy. J Neurol Neurosurg Psychiatry. 74:2003;1627-1630
21. Bernasconi N, Andermann F, Arnold DL, Bernasconi A. Entorhinal cortex MRI assessment in temporal, extratemporal, and idiopathic generalized epilepsy. Epilepsia. 44:2003;1070-1074
22. Natsume J, Bernasconi N, Andermann F, Bernasconi A. MRI volumetry of the thalamus in temporal, extratemporal, and idiopathic generalized epilepsy. Neurology. 60:2003;1296-1300
23. DeCarli C, Hatta J, Fazilat S, Fazilat S, Gaillard WD, Theodore WH. Extratemporal atrophy in patients with complex partial seizures of left temporal origin. Ann Neurol. 43:1998;41-45
24. Moran NF, Lemieux L, Kitchen ND, Fish DR, Shorvon SD. Extrahippocampal temporal lobe atrophy in temporal lobe epilepsy and mesial temporal sclerosis. Brain. 124:2001;167-175
25. Connelly A, Jackson GD, Duncan JS, King MD, Gadian DG. Magnetic resonance spectroscopy in temporal lobe epilepsy. Neurology. 44:1994;1411-1417
26. Knowlton RC, Laxer KD, Klein G, et al. In vivo hippocampal glucose metabolism in mesial temporal lobe epilepsy. Neurology. 57:2001;1184-1190
27. Chassoux F, Semah F, Bouilleret V, et al. Metabolic changes and electro-clinical patterns in mesio-temporal lobe epilepsy: a correlative study. Brain. 127:2004;164-174
28. Bouilleret V, Dupont S, Spelle L, Baulac M, Samson Y, Semah F. Insular cortex involvement in mesiotemporal lobe epilepsy: a positron emission tomography study. Ann Neurol. 51:2002;202-208
29. Dupont S, Semah F, Baulac M, Samson Y. The underlying pathophysiology of ictal dystonia in temporal lobe epilepsy: an FDG-PET study. Neurology. 51:1998;1289-1292
30. Newton MR, Berkovic SF, Austin MC, Reutens DC, McKay WJ, Bladin PF. Dystonia, clinical lateralization, and regional blood flow changes in temporal lobe seizures. Neurology. 42:1992;371-377
31. Blumenfeld H, McNally KA, Vanderhill SD, et al. Positive and negative network correlations in temporal lobe epilepsy. Cereb Cortex. 14:2004;892-902
32. Van Paesschen W, Dupont P, Van Driel G, Van Billoen H, Maes A. SPECT perfusion changes during complex partial seizures in patients with hippocampal sclerosis. Brain. 126:2003;1103-1111
33. Savic I, Ingvar M, Stone-Elander S. Comparison of [11C]flumazenil and [18F]FDG as PET markers of epileptic foci. J Neurol Neurosurg Psychiatry. 56:1993;615-621
34. Henry TR, Frey KA, Sackellares JC, et al. In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology. 43:1993;1998-2006
35. Juhasz C, Chugani DC, Muzik O, et al. Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome. Neurology. 56:2001;1650-1658
36. Koepp MJ, Richardson MP, Brooks DJ, et al. Cerebral benzodiazepine receptors in hippocampal sclerosis: an objective in vivo analysis. Brain. 119:1996;1677-1687
37. Labbe C, Froment JC, Kennedy A, Ashburner J, Cinotti L. Positron emission tomography metabolic data corrected for cortical atrophy using magnetic resonance imaging. Alzheimer Dis Assoc Disord. 10:1996;141-170
38. Meltzer CC, Zubieta JK, Links JM, Brakeman P, Stumpf MJ, Frost JJ. MR-based correction of brain PET measurements for heterogeneous gray matter radioactivity distribution. J Cereb Blood Flow Metab. 16:1996;650-658
39. Koepp MJ, Richardson MP, Labbe C, et al. [11C]flumazenil PET, volumetric MRI, and quantitative pathology in mesial temporal lobe epilepsy. Neurology. 49:1997;764-773
40. Koepp MJ, Labbe C, Richardson MP, et al. Regional hippocampal [11C]flumazenil PET in temporal lobe epilepsy with unilateral and bilateral hippocampal sclerosis. Brain. 120:1997;1865-1876
41. Ryvlin P, Bouvard S, Le Bars D, et al. Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy: a prospective study in 100 patients. Brain. 121:1998;2067-2081
42. Hand KS, Baird VH, Van Paesschen W, et al. Central benzodiazepine receptor autoradiography in hippocampal sclerosis. Br J Pharmacol. 122:1997;358-364
43. Koepp MJ, Hand KS, Labbe C, et al. In vivo [11C]flumazenil-PET correlates with ex vivo [3H]flumazenil autoradiography in hippocampal sclerosis. Ann Neurol. 43:1998;618-626
44. Hammers A, Koepp MJ, Labbe C, et al. Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsy. Neurology. 56:2001;897-906
45. Mayberg HS, Sadzot B, Meltzer CC, et al. Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography. Ann Neurol. 30:1991;3-11
46. Theodore WH, Carson RE, Andreasen P, et al. PET imaging of opiate receptor binding in human epilepsy using [18F]cyclofoxy. Epilepsy Res. 13:1992;129-139
47. Madar I, Lesser RP, Krauss G, et al. Imaging of delta- and mu-opioid receptors in temporal lobe epilepsy by positron emission tomography. Ann Neurol. 41:1997;358-367
48. Banati RB, Goerres GW, Myers R, et al. [11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology. 53:1999;2199-2203
49. Sauvageau A, Desjardins P, Lozeva V, et al. Increased expression of "peripheral-type" benzodiazepine receptors in human temporal lobe epilepsy: implications for PET imaging of hippocampal sclerosis. Metab Brain Dis. 17:2002;3-11
50. Kumlien E, Nilsson A, Hagberg G, Langstrom B, Bergstrom M. PET with 11C-deuterium-deprenyl and 18F-FDG in focal epilepsy. Acta Neurol Scand. 103:2001;360-366
51. Toczek MT, Carson RE, Lang L, et al. PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology. 60:2003;749-756
52. Muzik O, Chugani DC, Chakraborty P, Mangner T, Chugani HT. Analysis of [C-11]alpha-methyl-tryptophan kinetics for the estimation of serotonin synthesis rate in vivo. J Cereb Blood Flow Metab. 17:1997;659-669
53. Merlet I, Ryvlin P, Costes N, et al. Statistical parametric mapping of 5-HT(1A) receptor binding in temporal lobe epilepsy with hippocampal ictal onset on intracranial EEG. Neuroimage. 22:2004;886-896
54. Natsume J, Kumakura Y, Bernasconi N, et al. Alpha-[11C] methyl-L-tryptophan and glucose metabolism in patients with temporal lobe epilepsy. Neurology. 60:2003;756-761
55. Savic I, Lindstrom P, Gulyas B, Halldin C, Andree B, Farde L. Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy. Neurology. 62:2004;1343-1351
56. Pennell PB. PET: cholinergic neuroreceptor mapping. Adv Neurol. 83:2000;157-163
57. Kumlien E, Hartvig P, Valind S, Oye I, Tedroff J, Langstrom B. NMDA-receptor activity visualized with (S)-[N-methyl-11C]ketamine and positron emission tomography in patients with medial temporal lobe epilepsy. Epilepsia. 40:1999;30-37
58. Koepp MJ, Hammers A, Labbe C, Woermann FG, Brooks DJ, Duncan JS. 11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI. Neurology. 54:2000;332-339
59. Hammers A, Koepp MJ, Hurlemann R, et al. Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI. Brain. 125:2002;2257-2271
60. Hammers A, Koepp MJ, Richardson MP, Hurlemann R, Brooks DJ, Duncan JS. Grey and white matter flumazenil binding in neocortical epilepsy with normal MRI: a PET study of 44 patients. Brain. 126:2003;1300-1318
61. Richardson MP, Koepp MJ, Brooks DJ, Fish DR, Duncan JS. Benzodiazepine receptors in focal epilepsy with cortical dysgenesis: an 11C-flumazenil PET study. Ann Neurol. 40:1996;188-198
62. Richardson MP, Koepp MJ, Brooks DJ, et al. Cerebral activation in malformations of cortical development. Brain. 121:1998;1295-1304
63. Hammers A, Koepp MJ, Richardson MP, et al. Central benzodiazepine receptors in malformations of cortical development: a quantitative study. Brain. 124:2001;1555-1565
64. Hammers A, Koepp MJ, Richardson MP, Brooks DJ, Duncan JS. [11C]-diprenorphine PET in malformations of cortical development. Epilepsia. 42:(suppl 7):2001;100
65. Chugani DC, Chugani HT, Muzik O, et al. Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography. Ann Neurol. 44:1998;858-866
66. Asano E, Chugani DC, Muzik O, et al. Multimodality imaging for improved detection of epileptogenic foci in tuberous sclerosis complex. Neurology. 54:2000;1976-1984
67. Fedi M, Reutens DC, Andermann F, et al. Alpha-[11C]-Methyl-L-tryptophan PET identifies the epileptogenic tuber and correlates with interictal spike frequency. Epilepsy Res. 52:2003;203-213
68. Fedi M, Reutens D, Okazawa H, et al. Localizing value of alpha-methyl-L-tryptophan PET in intractable epilepsy of neocortical origin. Neurology. 57:2001;1629-1636
69. Rugg-Gunn FJ, Eriksson SH, Symms MR, Barker GJ, Duncan JS. Diffusion tensor imaging of cryptogenic and acquired partial epilepsies. Brain. 124:2001;627-636
70. Rugg-Gunn FJ, Eriksson SH, Boulby PA, Symms MR, Barker GJ, Duncan JS. Magnetization transfer imaging in focal epilepsy. Neurology. 60:2003;1638-1645
71. Salmenpera T, Symms M, Rugg-Gunn FJ, et al. Imaging the neocortex in epilepsy with advanced magnetic resonance imaging techniques. Epilepsia. 45:(suppl 3):2004;179
72. Woermann FG, McLean MA, Bartlett PA, Parker GJ, Barker GJ, Duncan JS. Short echo time single-voxel 1H magnetic resonance spectroscopy in magnetic resonance imaging-negative temporal lobe epilepsy: different biochemical profile compared with hippocampal sclerosis. Ann Neurol. 45:1999;369-376
73. Debets RM, Sadzot B, van Isselt JW, et al. Is 11C-flumazenil PET superior to 18FDG PET and 123I-iomazenil SPECT in presurgical evaluation of temporal lobe epilepsy? J Neurol Neurosurg Psychiatry. 62:1997;141-150
74. Lamusuo S, Pitkanen A, Jutila L, et al. [11 C]Flumazenil binding in the medial temporal lobe in patients with temporal lobe epilepsy: correlation with hippocampal MR volumetry, T2 relaxometry, and neuropathology. Neurology. 54:2000;2252-2260
75. Richardson MP, Koepp MJ, Brooks DJ, Duncan JS. 11C-flumazenil PET in neocortical epilepsy. Neurology. 51:1998;485-492
76. Savic I, Thorell JO, Roland P. [11C]flumazenil positron emission tomography visualizes frontal epileptogenic regions. Epilepsia. 36:1995;1225-1232
77. Berkovic SF, McIntosh AM, Kalnins RM, et al. Preoperative MRI predicts outcome of temporal lobectomy: an actuarial analysis. Neurology. 45:1995;1358-1363
78. Spencer SS, Theodore WH, Berkovic SF. Clinical applications: MRI, SPECT, and PET. Magn Reson Imaging. 13:1995;1119-1124
79. Knowlton RC, Laxer KD, Ende G, et al. Presurgical multimodality neuroimaging in electroencephalographic lateralized temporal lobe epilepsy. Ann Neurol. 42:1997;829-837
80. von Oertzen J, Urbach H, Jungbluth S, et al. Standard magnetic resonance imaging is inadequate for patients with refractory focal epilepsy. J Neurol Neurosurg Psychiatry. 73:2002;643-647
81. Urbach H, Hattingen J, von Oertzen J, et al. MR imaging in the presurgical workup of patients with drug-resistant epilepsy. Am J Neuroradiol. 25:2004;919-926
82. Sisodiya SM. Malformations of cortical development: burdens and insights from important causes of human epilepsy. Lancet Neurol. 3:2004;29-38
83. Tassi L, Colombo N, Garbelli R, et al. Focal cortical dysplasia: neuropathological subtypes, EEG, neuroimaging and surgical outcome. Brain. 125:2002;1719-1732
84. Edwards JC, Wyllie E, Ruggeri PM, et al. Seizure outcome after surgery for epilepsy due to malformation of cortical development. Neurology. 55:2000;1110-1114
85. Sisodiya SM, Free SL, Stevens JM, Fish DR, Shorvon SD. Widespread cerebral structural changes in patients with cortical dysgenesis and epilepsy. Brain. 118:1995;1039-1050
86. Eriksson SH, Rugg-Gunn FJ, Symms MR, Barker GJ, Duncan JS. Diffusion tensor imaging in patients with epilepsy and malformations of cortical development. Brain. 124:2001;17-26
87. Antel SB, Collins DL, Bernasconi N, et al. Automated detection of focal cortical dysplasia lesions using computational models of their MRI characteristics and texture analysis. Neuroimage. 19:2003;1748-1759
88. Richardson MP, Friston KJ, Sisodiya S, et al. Cortical grey matter and benzodiazepine receptors in malformations of cortical development: a voxel-based comparison of structural and functional imaging data. Brain. 120:1997;1961-1973
89. Wilke M, Kassubek J, Ziyeh S, Schulze-Bonhage A, Huppertz HJ. Automated detection of gray matter malformations using optimized voxel-based morphometry: a systematic approach. Neuroimage. 20:2003;330-343
90. Bernasconi A, Antel SB, Collins DL, et al. Texture analysis and morphological processing of magnetic resonance imaging assist detection of focal cortical dysplasia in extra-temporal partial epilepsy. Ann Neurol. 49:2001;770-775
91. Bonilha L, Kobayashi E, Castellano G, et al. Texture analysis of hippocampal sclerosis. Epilepsia. 44:2003;1546-1550
92. Woermann FG, McLean MA, Bartlett PA, Barker GJ, Duncan JS. Quantitative short echo time proton magnetic resonance spectroscopic imaging study of malformations of cortical development causing epilepsy. Brain. 124:2001;427-436
93. Kim SK, Na DG, Byun HS, et al. Focal cortical dysplasia: comparison of MRI and FDG-PET. J Comput Assist Tomogr. 24:2000;296-302
94. Shoaf SE, Carson RE, Hommer D, et al. The suitability of [11C]-alpha-methyl-L-tryptophan as a tracer for serotonin synthesis: studies with dual administration of [11C] and [14C] labeled tracer. J Cereb Blood Flow Metab. 20:2000;244-252
95. Chugani DC, Chugani HT. PET: mapping of serotonin synthesis. Adv Neurol. 83:2000;165-171
96. Juhasz C, Chugani DC, Muzik O, et al. Alpha-methyl-L-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy. Neurology. 60:2003;960-968
97. Marusic P, Najm IM, Ying Z, et al. Focal cortical dysplasias in eloquent cortex: functional characteristics and correlation with MRI and histopathologic changes. Epilepsia. 43:2002;27-32
98. Diehl B, Salek-haddadi A, Fish DR, Lemieux L. Mapping of spikes, slow waves, and motor tasks in a patient with malformation of cortical development using simultaneous EEG and fMRI. Magn Reson Imaging. 21:2003;1167-1173
99. Janszky J, Ebner A, Kruse B, et al. Functional organization of the brain with malformations of cortical developmen. Ann Neurol. 53:2003;759-767
100. Dobyns WB, Truwi CL, Ross ME, et al. Differences in the gyral pattern distinguish chromosome 17-linked and X-linked lissencephaly. Neurology. 53:1999;270-277
101. Villard L, Nguyen K, Cardoso C, et al. A locus for bilateral perisylvian polymicrogyria maps to Xq28. Am J Hum Genet. 70:2002;1003-1008
102. Chang BS, Piao X, Bodell A, et al. Bilateral frontoparietal polymicrogyria: clinical and radiological features in 10 families with linkage to chromosome 16. Ann Neurol. 53:2003;596-606
103. Merschhemke M, Mitchell TN, Free SL, et al. Quantitative MRI detects abnormalities in relatives of patients with epilepsy and malformations of cortical development. Neuroimage. 18:2003;642-649
104. Mitchell TN, Free SL, Williamson KA, et al. Polymicrogyria and absence of pineal gland due to PAX6 mutation. Ann Neurol. 53:2003;658-663
105. Mitchell TN, Stevens JM, Free SL, Sander JW, Shorvon SD, Sisodiya SM. Anterior commissure absence without callosal agenesis: a new brain malformation. Neurology. 58:2002;1297-1299
106. Daumas-Duport C, Varlet P, Bacha S, Beuvon F, Cervera-Pierot P, Chodkiewicz JP. Dysembryoplastic neuroepithelial tumors: nonspecific histological forms - a study of 40 cases. J Neurooncol. 41:1999;267-280
107. Kaplan AM, Lawson MA, Spataro J, et al. Positron emission tomography using [18F] fluorodeoxyglucose and [11C] l-methionine to metabolically characterize dysembryoplastic neuroepithelial tumors. J Child Neurol. 14:1999;673-677
108. Richardson MP, Hammers A, Brooks DJ, Duncan JS. Benzodiazepine-GABA(A) receptor binding is very low in dysembryoplastic neuroepithelial tumor: a PET study. Epilepsia. 42:2001;1327-1334
109. Derlon JM, Petit-Taboue MC, Chapon F, et al. The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine. Neurosurgery. 40:1997;276-287
110. Maehara T, Nariai T, Arai N, et al. Usefulness of [11C]methionine PET in the diagnosis of dysembryoplastic neuroepithelial tumor with temporal lobe epilepsy. Epilepsia. 45:2004;41-45
111. Stanescu CR, Varlet P, Beuvon F, et al. Dysembryoplastic neuroepithelial tumors: CT, MR findings and imaging follow-up: a study of 53 cases. J Neuroradiol. 28:2001;230-240
112. Valenti MP, Froelich S, Armspach JP, et al. Contribution of SISCOM imaging in the presurgical evaluation of temporal lobe epilepsy related to dysembryoplastic neuroepithelial tumors. Epilepsia. 43:2002;270-276
113. Ogawa S, Lee TM, Kay AR, Tank DW. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci USA. 87:1990;9868-9872
114. Duyn JH, Yang Y, Frank JA, Mattay VS, Hou L. Functional magnetic resonance neuroimaging data acquisition techniques. Neuroimage. 4:1996;S76-83
115. Price CJ, Friston KJ. Scanning patients with tasks they can perform. Hum Brain Mapp. 8:1999;102-108
116. Binder JR, Frost JA, Hammeke TA, Bellgowan PS, Rao SM, Cox RW. Conceptual processing during the conscious resting state: a functional MRI study. J Cogn Neurosci. 11:1999;80-95
117. Price CJ, Mummery CJ, Moore CJ, Frakowiak RS, Friston KJ. Delineating necessary and sufficient neural systems with functional imaging studies of neuropsychological patients. J Cogn Neurosci. 11:1999;371-382
118. Woermann FG, Jokeit H, Luerding R, et al. Language lateralization by Wada test and fMRI in 100 patients with epilepsy. Neurology. 61:2003;699-701
119. Ramsey NF, Sommer IE, Rutten GJ, Kahn RS. Combined analysis of language tasks in fMRI improves assessment of hemispheric dominance for language functions in individual subjects. Neuroimage. 13:2001;719-733
120. Matthews PM, Adcock J, Chen Y, et al. Towards understanding language organisation in the brain using fMRI. Hum Brain Mapp. 18:2003;239-247
121. Fitzgerald DB, Cosgrove GR, Ronner S, et al. Location of language in the cortex: a comparison between functional MR imaging and electrocortical stimulation. Am J Neuroradiol. 18:1997;1529-1539
122. Pouratian N, Bookheimer SY, Rubino G, Martin NA, Toga AW. Category-specific naming deficit identified by intraoperative stimulation mapping and postoperative neuropsychological testing: case report. J Neurosurg. 99:2003;170-176
123. Rutten GJ, Ramsey NF, van Rijen PC, Noordmans HJ, van Veelen CW. Development of a functional magnetic resonance imaging protocol for intraoperative localization of critical temporoparietal language areas. Ann Neurol. 51:2002;350-360
124. Adcock JE, Wise RG, Oxbury JM, Oxbury SM, Matthews PM. Quantitative fMRI assessment of the differences in lateralization of language-related brain activation in patients with temporal lobe epilepsy. Neuroimage. 18:2003;423-438
125. Binder JR, Swanson SJ, Hammeke TA, et al. Determination of language dominance using functional MRI: a comparison with the Wada test. Neurology. 46:1996;978-984
126. Springer JA, Binder JR, Hammeke TA, et al. Language dominance in neurologically normal and epilepsy subjects: a functional MRI study. Brain. 122:1999;2033-2046
127. Bahn MM, Lin W, Silbergeld DL, et al. Localization of language cortices by functional MR imaging compared with intracarotid amobarbital hemispheric sedation. Am J Roentgenol. 169:1997;575-579
128. Lehericy S, Cohen L, Bazin B, et al. Functional MR evaluation of temporal and frontal language dominance compared with the Wada test. Neurology. 54:2000;1625-1633
129. Billingsley RL, McAndrews MP, Crawley AP, Mikulis DJ. Functional MRI of phonological and semantic processing in temporal lobe epilepsy. Brain. 124:2001;1218-1227
130. Sabsevitz DS, Swanson SJ, Hammeke TA, et al. Use of preoperative functional neuroimaging to predict language deficits from epilepsy surgery. Neurology. 60:2003;1788-1792
131. Grabowski TJ, Damasio H, Tranel D, et al. Residual naming after damage to the left temporal pole: a PET activation study. Neuroimage. 19:2003;846-860
132. Powell HW, Koepp MJ, Thompson P, Richardson M, Symms M, Duncan JS. The application of functional MRI of memory in temporal lobe epilepsy: a clinical review. Epilepsia. 45:2004;855-863
133. Zeineh MM, Engel SA, Thompson PM, Bookheimer SY. Dynamics of the hippocampus during encoding and retrieval of face-name pairs. Science. 299:2003;577-580
134. Bellgowan PS, Binder JR, Swanson SJ, et al. Side of seizure focus predicts left medial temporal lobe activation during verbal encoding. Neurology. 51:1998;479-484
135. Richardson MP, Strange BA, Duncan JS, Dolan RJ. Preserved verbal memory function in left medial temporal pathology involves reorganisation of function to right medial temporal lobe. Neuroimage. 20:(suppl 1):2003;S112-119
136. Richardson MP, Strange BA, Dolan RJ. Encoding of emotional memories depends on amygdala and hippocampus and their interactions. Nat Neurosci. 7:2004;278-285
137. Detre JA, Floyd TF. Functional MRI and its applications to the clinical neurosciences. Neuroscientist. 7:2001;64-79
138. Jokeit H, Okujava M, Woermann FG. Memory fMRI lateralizes temporal lobe epilepsy. Neurology. 57:2001;1786-1793
139. Janszky J, Ollech I, Jokeit H, et al. Epileptic activity influences the lateralisation of mesiotemporal fMRI activity. Neurology. 63:2004;1813-1817
140. Rabin ML, Narayan VM, Kimberg DY, et al. Functional MRI predicts post-surgical memory following temporal lobectomy. Brain. 127:2004;2286-2298
141. Richardson MP, Strange BA, Thompson PJ, Baxendale SA, Duncan JS, Dolan RJ. Pre-operative verbal memory fMRI predicts post-operative memory decline after left temporal lobe resection. Brain. 127:2004;2419-2426
142. Bancaud J, Talairach J. Clinical semiology of frontal lobe seizures. Adv Neurol. 57:1992;3-58
143. Isnard J, Guenot M, Ostrowsky K, Sindou M, Mauguiere F. The role of the insular cortex in temporal lobe epilepsy. Ann Neurol. 48:2000;614-623
144. Sisodiya SM, Moran N, Free SL, et al. Correlation of widespread preoperative magnetic resonance imaging changes with unsuccessful surgery for hippocampal sclerosis. Ann Neurol. 41:1997;490-496
145. Koepp MJ, Richardson MP, Brooks DJ, Duncan JS. Focal cortical release of endogenous opioids during reading-induced seizures. Lancet. 352:1998;952-955
146. Archer JS, Briellmann RS, Syngeniotis A, Abbott DF, Jackson GD. Spike-triggered fMRI in reading epilepsy: involvement of left frontal cortex working memory area. Neurology. 60:2003;415-421
147. Noppeney U, Price CJ. An fMRI study of synaptic adaptation. J Cogn Neurosci. 16:2004;702-713
148. Yoon HH, Kwon HL, Mattson RH, Spencer DD, Spencer SS. Long-term seizure outcome in patients initially seizure-free after resective epilepsy surgery. Neurology. 61:2003;445-450
149. Toosy AT, Ciccarelli O, Parker GJ, Wheeler-Kingshott CA, Miller DH, Thompson AJ. Characterizing function-structure relationships in the human visual system with functional MRI and diffusion tensor imaging. Neuroimage. 21:2004;1452-1463
150. Guye M, Parker GJ, Symms M, et al. Combined functional MRI and tractography to demonstrate the connectivity of the human primary motor cortex in vivo. Neuroimage. 19:2003;1349-1360
151. Powell HW, Guye M, Parker GJ, et al. Noninvasive in vivo demonstration of the connections of the human parahippocampal gyrus. Neuroimage. 22:2004;740-747